SOLSTICE trial data demonstrate that 66% of chronic hepatitis delta participants receiving a monthly dose of tobevibart and elebsiran achieved undetectable HDV RNA at Week 48 Combination ...
(MENAFN- EIN Presswire) EINPresswire/ -- Goody PR agency is honored to receive two top 2025 MarCom Awards – Platinum level for two categories: 1. Best Public Relations Program and 2. Best Publicity ...